Acute Right-Heart Failure in Patients with Chronic Precapillary Pulmonary Hypertension

[1]  M. Aschermann,et al.  The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension , 2021, PloS one.

[2]  Robert A. Lewis,et al.  BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing? , 2020, European Respiratory Review.

[3]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): supplementary data , 2019 .

[4]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[5]  R. Benza,et al.  Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies. , 2019, Chest.

[6]  P. Corris,et al.  Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension , 2019, European Respiratory Journal.

[7]  J. Lumens,et al.  Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update , 2019, European Respiratory Journal.

[8]  Z. Jing,et al.  Risk stratification and medical therapy of pulmonary arterial hypertension , 2019, European Respiratory Journal.

[9]  M. Humbert,et al.  Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives , 2019, European Respiratory Journal.

[10]  Paul G. Williams,et al.  Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.

[11]  H. Ghofrani,et al.  Chronic thromboembolic pulmonary hypertension , 2004, European Respiratory Journal.

[12]  N. Manjunatha,et al.  The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery - A Pilot Randomized Double-Blind Study. , 2018, Journal of cardiothoracic and vascular anesthesia.

[13]  I. Douglas,et al.  Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement , 2018, American journal of respiratory and critical care medicine.

[14]  J. Nielsen-Kudsk,et al.  Levosimendan in pulmonary hypertension and right heart failure , 2018, Pulmonary circulation.

[15]  Ami A. Shah,et al.  Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension , 2018, Circulation.

[16]  M. Humbert,et al.  Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension , 2017, Circulation.

[17]  P. Jaksch,et al.  Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  M. Humbert,et al.  Acute decompensated pulmonary hypertension , 2017, European Respiratory Review.

[19]  K. Dimopoulos,et al.  The CRASH report: emergency management dilemmas facing acute physicians in patients with pulmonary arterial hypertension , 2017, Thorax.

[20]  M. Humbert,et al.  Impact of High-Priority Allocation on Lung and Heart-Lung Transplantation for Pulmonary Hypertension. , 2017, The Annals of thoracic surgery.

[21]  J. Newman,et al.  Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle. , 2016, American journal of respiratory and critical care medicine.

[22]  E. Fadel,et al.  Extracorporeal life support in lung and heart–lung transplantation for pulmonary hypertension in adults , 2016, Clinical transplantation.

[23]  P. Dartevelle,et al.  Extracorporeal Life Support After Pulmonary Endarterectomy as a Bridge to Recovery or Transplantation: Lessons From 31 Consecutive Patients. , 2016, The Annals of thoracic surgery.

[24]  C. Ottenheijm,et al.  Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension , 2016, Circulation. Heart failure.

[25]  M. Goumans,et al.  Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle , 2016, Circulation.

[26]  J. Voigt,et al.  Is Right Ventricular Remodeling in Pulmonary Hypertension Dependent on Etiology? An Echocardiographic Study , 2016, Echocardiography.

[27]  R. Gerszten,et al.  Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension , 2016, Circulation.

[28]  G. Filippatos,et al.  Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology , 2016, European journal of heart failure.

[29]  Stephen Kaptoge,et al.  BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis , 2016, The Lancet. Respiratory medicine.

[30]  N. Serkova,et al.  Severe pulmonary hypertension is associated with altered right ventricle metabolic substrate uptake. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[31]  J. Barberà,et al.  Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. , 2015, The New England journal of medicine.

[32]  Z. Jing,et al.  Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension , 2015, Hypertension Research.

[33]  S. Ye,et al.  Severe pulmonary arterial hypertension secondary to lupus in the emergency department: proactive intense care associated with a better short‐term survival , 2015, International journal of rheumatic diseases.

[34]  T. Welte,et al.  Lung Transplantation for Severe Pulmonary Hypertension—Awake Extracorporeal Membrane Oxygenation for Postoperative Left Ventricular Remodelling , 2015, Transplantation.

[35]  H. Ghofrani,et al.  Selexipag for the Treatment of Pulmonary Arterial Hypertension. , 2014, The New England journal of medicine.

[36]  M. Humbert,et al.  Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension , 2014, Circulation.

[37]  S. Ringgaard,et al.  Acute Effects of Levosimendan in Experimental Models of Right Ventricular Hypertrophy and Failure , 2014, Pulmonary circulation.

[38]  C. Witt,et al.  Introduction of the Lung Allocation Score in Germany , 2014, American Journal of Transplantation.

[39]  J. Marcus,et al.  The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension. , 2014, Chest.

[40]  Z. Jing,et al.  Macitentan and morbidity and mortality in pulmonary arterial hypertension. , 2013, The New England journal of medicine.

[41]  R. Dweik,et al.  Causes and circumstances of death in pulmonary arterial hypertension. , 2013, American journal of respiratory and critical care medicine.

[42]  H. Mallidi,et al.  Transplantation for Idiopathic Pulmonary Arterial Hypertension: Improvement in the Lung Allocation Score Era , 2013, Circulation.

[43]  P. Marik,et al.  Noninvasive cardiac output monitors: a state-of the-art review. , 2013, Journal of cardiothoracic and vascular anesthesia.

[44]  Thanh N. Huynh,et al.  Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit. , 2012, Journal of critical care.

[45]  M. Humbert,et al.  Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[46]  M. Humbert,et al.  Renal Replacement Therapy in Patients with Severe Precapillary Pulmonary Hypertension with Acute Right Heart Failure , 2012, Respiration.

[47]  J. Granton,et al.  Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. , 2011, American journal of respiratory and critical care medicine.

[48]  A. Denault,et al.  Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension , 2011, Circulation. Heart failure.

[49]  S. Hazen,et al.  Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension , 2011, European Respiratory Journal.

[50]  S. Brett,et al.  Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review , 2010, Critical care.

[51]  R. Naeije,et al.  Optimising the management of pulmonary arterial hypertension patients: emergency treatments , 2010, European Respiratory Review.

[52]  M. Humbert,et al.  Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era , 2010, Circulation.

[53]  Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative , 2009, European heart journal.

[54]  M. Humbert,et al.  Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension , 2009, European Respiratory Journal.

[55]  T. Welte,et al.  Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[56]  Kohtaro Abe,et al.  The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. , 2009, Chest.

[57]  F. Laenger,et al.  Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[58]  A. Torbicki,et al.  Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension. , 2008, Kardiologia polska.

[59]  Sanjiv J. Shah,et al.  Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension , 2008, Circulation.

[60]  M. Humbert,et al.  Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. , 2008, Arthritis and rheumatism.

[61]  H. Akashi,et al.  Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. , 2007, Interactive cardiovascular and thoracic surgery.

[62]  M. Buckley,et al.  Nebulized Milrinone Use in a Pulmonary Hypertensive Crisis , 2007, Pharmacotherapy.

[63]  Steven Q. Davis,et al.  Organ allocation in lung transplant. , 2007, Chest.

[64]  Frank J Giordano,et al.  Oxygen, oxidative stress, hypoxia, and heart failure. , 2005, The Journal of clinical investigation.

[65]  R. Naeije,et al.  Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure* , 2004, Critical care medicine.

[66]  C. S. Lee,et al.  The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension* , 2002, Anaesthesia.

[67]  F. Fedele,et al.  Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension , 2001, Critical care.